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nz 
Lyme Disease 
in Urban Areas, 
Chicago
To the Editor: Lyme disease is a 
multisystem illness caused by infec-
tion with the tickborne spirochete Bor-
relia burgdorferi. Most infections in 
the United States occur in the North-
east and upper Midwest, and the mid-
western focus now includes Illinois 
(1,2). Previously, the greatest risk of 
contracting Lyme disease in the Mid-
west was conﬁ  ned to the northernmost 
states (Wisconsin and Minnesota) and 
did not encroach into heavily popu-
lated areas around the city of Chicago. 
However, we showed recently that B. 
burgdorferi–infected Ixodes scapular-
is ticks were recovered from sites in 
Cook and DuPage counties (3), but the 
percentages of infected ticks were low 
(<5%). Since that time, however, re-
ports of Lyme disease in Cook County 
have been reviewed and individual I. 
scapularis tick submissions from Lake 
County, north of Chicago, have been 
received. We therefore surveyed new 
areas north of Chicago (closest was <1 
mile from the city limits; farthest was 
≈25 miles from the city limits) and ex-
amined additional ticks for infection 
with B. burgdorferi.
From December 2006 to May 
2007, we collected 172 adult I. scapu-
laris ticks from sites to the north and 
northwest of Chicago (Figure). Adult 
ticks were collected because nymph-
al ticks are more difﬁ  cult to obtain, 
and the infection rate in adult ticks 
is similar (1). The tick midguts were 
removed aseptically, inoculated into 
tubes containing 1 mL of modiﬁ  ed 
Barbour-Stoenner-Kelly medium (4), 
incubated at 35ºC, and examined for 
spirochetes for up to 3 weeks. Spiro-
chetes were recovered from 21 (32%) 
of 65 ticks and 40 (37%) of 107 ticks 
collected from sites in Cook and Lake 
counties, respectively.  In addition, 
PCR using primers speciﬁ  c for outer 
surface protein A (5) conﬁ  rmed that 
the spirochetes were B. burgdorferi.
The  ﬁ   ndings demonstrate that 
the midwestern endemic focus of 
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Figure. Sites surrounding Chicago from which Borrelia burgdorferi–infected  Ixodes 
scapularis ticks were recovered in 2005–2006 () and 2006–2007 (z).LETTERS
B. burgdorferi–infected I. scapularis 
now includes northern Cook and Lake 
counties. More importantly, the high 
percentage of B. burgdorferi–infected 
ticks in this region conﬁ  rms a newly 
recognized signiﬁ   cant risk of Lyme 
disease in suburban areas adjacent to 
Chicago (population ≈7 million). Re-
cently, the Infectious Diseases Society 
of America recommended that clini-
cians consider prescribing a single 
prophylactic dose of doxycycline (200 
mg) when patients have received tick 
bites in areas where the percentage of 
B. burgdorferi–infected I. scapularis 
exceeds 20% (6,7). The high percent-
age of infected adult ticks identiﬁ  ed 
in this survey highlights the need for 
physicians in the Chicago area to be-
come familiar with this recommenda-
tion, especially considering the high 
likelihood that nymphal I. scapularis 
ticks are similarly infected (1). More-
over, conﬁ   rmation of the increasing 
risk of contracting Lyme disease near 
metropolitan Chicago should provide 
impetus for more comprehensive stud-
ies to completely deﬁ  ne the risk of this 
potentially serious illness.
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Oral Versus IV 
Treatment for
Catheter-related 
Bloodstream 
Infections
To the Editor: I read with inter-
est the article by Halton and Graves 
on the economics of catheter-related 
blood stream infections (1). The most 
important determinants of infection 
in a temporary central venous cath-
eter (CVC) are location and duration 
(2). Also important are aseptic CVC 
insertion and maintenance. Reducing 
the economic effects of CVCs is im-
portant, but I believe clinicians should 
use oral antimicrobial agents more of-
ten in place of intravenous (IV) anti-
microbial therapy.
The economic and clinical ben-
eﬁ  ts of using oral versus intravenous 
antimicrobial therapy are consider-
able. Oral therapy has important ad-
vantages over intravenous therapy 
administered via CVCs. Clinical ad-
vantages of oral antimicrobial therapy 
include the elimination of phlebitis 
CVC line infections. At equivalent 
doses, acquisition costs of oral agents 
are less than intravenous counterparts. 
Healthcare institutions charge IV ad-
ministration fees per antimicrobial 
intravenous dose. Administrative cost 
for intravenous antimicrobial agents 
is US $10/dose. Intravenous antimi-
crobial administration costs are elimi-
nated when drugs are administered 
orally. In hospitalized patients, oral 
antimicrobial therapy results in a de-
creased hospital length of stay with its 
attendant economic implications.
Oral therapy for serious systemic 
infections should be with high bio-
availability drugs, i.e., >90%, which 
results in essentially the same serum/
tissue levels as if when administered 
by IV.  Because all parenteral anti-
microbial agents do not have an oral 
formulation, clinicians should select 
an equivalent oral agent with the same 
spectrum as its parenteral counterpart 
1800  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 11, November 2007